Summary of the Study

Panic disorder is a type of anxiety disorder. It causes panic attacks, which are sudden feelings of terror when there is no real danger. Physical symptoms of panic disorder include fast heartbeat, chest or stomach pain, breathing difficulty, weakness or dizziness, sweating, feeling hot or a cold chill and tingly or numb hands.

A 1996 report published by the World Health Organization and the Harvard School of Public Health stated that panic disorder was the fifth most disabling mental health problem in the developed world.

It’s estimated that almost 1 to 2 % of the general population will suffer with panic disorder in any given year, and approximately 5 percent of the population will experience panic disorder at some point in their lives. However, a recent research suggests that 13.2% of people have experienced a panic attack at some point in their lives.

In order to help healthcare companies working in the area of Anti-Panic Drugs, our firm Mark IP has prepared a very detailed Patent Landscape Report on Anti-Panic Drugs covering patent data from 1983 to Till-date!

The first patent in the field of Anti-Panic Drugs was filed in the United States in 1897 by Upjohn Company. US Patent 4481208A claims the therapeutic uses of 6-phenyl-8-chloro-4H-s-triazolo 4, 3-a 1, 4-benzodiazepine including the N-oxides and pharmacologically acceptable acid addition salts in treating panic disorders in humans. Upjohn's 1983 patent claim benzodiazepine as anti-panic drugs, it is interesting to note that now benzodiazepines are the most selling anti-panic drugs! 

From 1983 to 1990 very few patent applications were filed in this area, on average 03 patent families per year was filed! From 1991 to 2000, on average 51 patent families per year was filed.  Post 2000, the patent filing activity in this domain considerably increased, on average 196 patent families per year were filed in between 2000-2010. Post 2010, the patent filing activity in this domain decreased by 50%, on average 93 patent families per year was filed in between 2011-2018.

A recent Patent Literature search shows that nearly 3,500 patent families contain the root words when Panic* or (Panic NEAR5 (disorder? OR attack? Or disease? Or anxiolytic or syndrome?)) is searched in the Title, Abstract and Claims. IPC Classification code A61P002522 is also searched and added to the results.

Mark IP's analysts have manually screened 3,500 patent families containing the word panic in the title, abstract and claims filed all over the world and they bucketed the relevant patent families to First and Second Level Taxonomy.  In addition, Mark IP has collected details about the following.

1. Types of Chemical Compounds Used as Anti-panic drugs

2. Processes used for synthesizing anti-panic drugs

3. Formulations, Assays etc.

Thus, the Mark IP's patent landscape report on anti-panic drugs, which covers last ~40 years of patent data, would be highly useful to pharmaceutical companies developing anti-panic or anti-psychotic drugs!